Anticancer, antimicrobial and biomedical features of polyoxometalate as advanced materials: A review study

Mousavi, Seyyed Mojtaba and Hashemi, Seyyed Alireza and Mazraedoost, Sargol and Chiang, Wei-Hung and Yousefi, Khadije and Arjmand, Omid and Ghahramani, Yasmin and Gholami, Ahmad and Omidifar, Navid and Rumjit, Nelson Pynadathu and Salari, Marjan and Sadrmousavi-Dizaj, Asma (2022) Anticancer, antimicrobial and biomedical features of polyoxometalate as advanced materials: A review study. INORGANIC CHEMISTRY COMMUNICATIONS, 146. ISSN 1879-0259, DOI https://doi.org/10.1016/j.inoche.2022.110074.

Full text not available from this repository.
Official URL: https://doi.org/10.1016/j.inoche.2022.110074

Abstract

Polyoxometalate(POMs) is an oligomeric cluster of transition metal oxoanions that has a well-defined infra-structure with a wide range of sizes, metal-oxygen frameworks, chemical compositions, and unparalleled properties. In the fields of catalysis, materials chemistry, and biochemistry, they are among the most attractive and fastest growing areas of research. Moreover, some POMs and their derivatives are capable of exhibiting antibacterial, antiviral, antitumor, and anticancer properties, in addition to their many valuable properties. Several studies have demonstrated the efficacy of some of these agents in the treatment of symptoms associated with diabetes. Because of these properties, POMs have always been of interest to researchers. In this review, an overview of the biomedical applications of POMs, including their role in pharmaceuticals, is provided based on various scientific publications.

Item Type: Article
Funders: UNSPECIFIED
Uncontrolled Keywords: POMs; Synthesis method; Anti -viral; Antibacterial; Anti -tumour
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Nanotechnology & Catalysis Research Centre
Depositing User: Ms Koh Ai Peng
Date Deposited: 25 Oct 2024 01:40
Last Modified: 25 Oct 2024 01:40
URI: http://eprints.um.edu.my/id/eprint/46182

Actions (login required)

View Item View Item